Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Oxytocin ELISA Kit (AC3749)
Cat.#: ASET-2338
Specifications
Description Oxytocin ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of Oxytocin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Universal Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1769 Rat GRK2 ELISA Kit (AC3180) Quantitative inquiry ASET-2164 Rat GDF6 ELISA Kit (AC3575) Quantitative inquiry ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry ASET-2100 Rat TrkB ELISA Kit (AC3511) Quantitative inquiry ASET-2193 Human Robo4 ELISA Kit (AC3604) Quantitative inquiry ASET-2241 Mouse Robo4 ELISA Kit (AC3652) Quantitative inquiry ASET-1695 Mouse Wnt6 ELISA Kit (AC3106) Quantitative inquiry ASET-1409 Rat SLC26A4 ELISA Kit (AC2820) Quantitative inquiry ASET-1294 Rat beta Arrestin 1 ELISA Kit (AC2705) Quantitative inquiry ASET-2269 Human GDF6 ELISA Kit (AC3680) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket